Hims & Hers Health (HIMS) News Today → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free HIMS Stock Alerts $20.36 +0.78 (+3.98%) (As of 05/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 7:04 AM | insidertrades.comSoleil Boughton Sells 2,502 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockMay 31 at 5:09 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Short Interest Up 20.3% in MayHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 22,130,000 shares, a growth of 20.3% from the April 30th total of 18,390,000 shares. Currently, 14.7% of the company's stock are sold short. Based on an average daily trading volume, of 8,300,000 shares, the short-interest ratio is presently 2.7 days.May 30 at 10:58 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21.16Hims & Hers Health (NYSE:HIMS) Sets New 1-Year High at $21.16May 30 at 7:00 AM | marketbeat.comCall Option Volumes Spiked For These 3 StocksAs the saying goes, always follow the money. This time, investors can follow the proverbial big players through an options activity screener, spotting unusual trends in how markets are betting.May 30 at 7:00 AM | marketbeat.comCall Option Volumes Spiked For These 3 Stocks (HIMS)Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decisionMay 30 at 6:01 AM | marketbeat.comTrexquant Investment LP Purchases New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)Trexquant Investment LP acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 124,469 shares of the company's stock, valued at approxMay 30 at 1:21 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) have been given an average rating of "Moderate Buy" by the fifteen brokerages that are covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and eight have issued a buyMay 29 at 7:48 PM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $43,359.66 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,502 shares of the firm's stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total value of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares of the company's stock, valued at $2,718,297.15. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 29 at 2:16 PM | benzinga.comSmart Money Is Betting Big In HIMS OptionsMay 28 at 2:45 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseMay 28 at 8:41 AM | marketbeat.comLifeMD Can Surge on Its GLP-1 Offerings (HIMS)LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a resultMay 26, 2024 | fool.comThe Ultimate Growth Stock to Buy With $20 Right NowMay 26, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Stock Price Up 5.7%May 24, 2024 | theglobeandmail.comIs Hims & Hers Stock a Buy for GLP-1 Upside?May 24, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Up 5.7%Hims & Hers Health (NYSE:HIMS) Trading 5.7% HigherMay 24, 2024 | investorplace.com7 Stocks to Dominate in the Next Economic UpturnMay 23, 2024 | msn.comHims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDAMay 23, 2024 | msn.comCitigroup Downgrades Hims & Hers Health (HIMS)May 23, 2024 | markets.businessinsider.comNavigating 10 Analyst Ratings For Hims & Hers HealthMay 23, 2024 | investorplace.comMove Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.May 23, 2024 | americanbankingnews.comCitigroup Lowers Hims & Hers Health (NYSE:HIMS) to NeutralMay 23, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) PT Raised to $24.00 at Canaccord Genuity GroupMay 23, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Gap Down Following Insider SellingMay 22, 2024 | finance.yahoo.comNvidia earnings, housing market outlook, BNPL regulatory pressure: Market DominationMay 22, 2024 | msn.comHims & Hers Is Now Selling Semaglutide: Here's What You Should KnowMay 22, 2024 | investorplace.comThe Growth Stock Shuffle: 2 to Ditch and 1 to OwnMay 22, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Price Target Raised to $24.00 at Canaccord Genuity GroupCanaccord Genuity Group boosted their target price on Hims & Hers Health from $20.00 to $24.00 and gave the stock a "buy" rating in a research note on Wednesday.May 22, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Gap Down After Insider SellingHims & Hers Health (NYSE:HIMS) Shares Gap Down After Insider SellingMay 22, 2024 | msn.comHims & Hers cut to Neutral at Citi on recent rallyMay 22, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Downgraded by Citigroup to NeutralCitigroup downgraded shares of Hims & Hers Health from a "buy" rating to a "neutral" rating and upped their price target for the stock from $16.00 to $20.00 in a research report on Wednesday.May 22, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $98,349.15 in StockMay 22, 2024 | fool.comHims & Hers Is Changing the GameMay 22, 2024 | americanbankingnews.comTraders Buy High Volume of Call Options on Hims & Hers Health (NYSE:HIMS)May 21, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,915 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 4,915 shares of the business's stock in a transaction on Monday, May 20th. The shares were sold at an average price of $20.01, for a total value of $98,349.15. Following the completion of the sale, the insider now owns 159,357 shares of the company's stock, valued at $3,188,733.57. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.May 21, 2024 | msn.comHims & Hers is selling an Ozempic knockoff without FDA approval. Here's howMay 21, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseHims & Hers Health (NYSE:HIMS) Sees Large Volume IncreaseMay 21, 2024 | msn.comHims & Hers Health says it will offer compounded GLP-1 injectionsMay 21, 2024 | marketbeat.comMckinley Capital Management LLC Purchases 231,867 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)Mckinley Capital Management LLC boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 34.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 896,020 shares of the company's stock aftMay 21, 2024 | seekingalpha.comHims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility AheadMay 21, 2024 | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 943 Shares of StockMay 21, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 943 SharesMay 20, 2024 | msn.comWellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock SoarsMay 20, 2024 | msn.comHims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To WegovyMay 20, 2024 | msn.comHims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec saysMay 20, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 943 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Irene Becklund sold 943 shares of the stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $14.50, for a total value of $13,673.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.May 20, 2024 | msn.comTop Stock Movers Now: Jabil, Norwegian Cruise Line, Hims & Hers Health, and MoreMay 20, 2024 | msn.comHims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutideMay 20, 2024 | markets.businessinsider.comHims & Hers Health’s Strategic Growth in Weight Loss Market Warrants Buy Rating Despite Regulatory RisksMay 20, 2024 | msn.comHims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.May 20, 2024 | investopedia.comHims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address 1k a day while computer does all work? (Ad)Does your computer make you 1k a day? If not… you don’t need a new computer… You need to learn how to set it up so it makes you money. Click here to register. HIMS Media Mentions By Week HIMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.400.82▲Average Medical News Sentiment HIMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼188▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TDOC News Today AUNA News Today LFMD News Today AIRS News Today SHLT News Today TOI News Today CCM News Today BMRN News Today NBIX News Today RVTY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarElon Musk’s Final Masterpiece: “X-9840”Paradigm PressBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
